Task: Answer the MCQ question.
Question: Which drug exhibits a 18.193% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a COc1ccc2c(c1)CC/C(=C\c1ccc(OC)c(Cn3cccn3)c1)C2=O
b CCC(=O)NC(NC(=S)Nc1ccccc1Br)C(Cl)(Cl)Cl
Answer: b. CCC(=O)NC(NC(=S)Nc1ccccc1Br)C(Cl)(Cl)Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)NC(NC(=S)Nc1ccccc1Br)C(Cl)(Cl)Cl
CCC(=O)NC(NC(=S)Nc1ccccc1Br)C(Cl)(Cl)Cl
N-[1-[(2-bromophenyl)carbamothioylamino]-2,2,2-trichloroethyl]propanamide